To note, a huge market segment is are already paying thousands of dollars per yer, right now, on skin care (for instance the SK-II lineup sells well, and it’s 100-250$ a bottle)
My semi-cynical view would be that cosmetics companies don’t have any specific incentive to accelerate the natural march of research as long as they stay on the forefront of it and have top of the line products. Basically they’d only have issues with new players making bolstering entrances and disrupting their market with a revolutionary products they’re not ready to counter.
And the gap between some process being validated, and a product with that process being on the market is so huge, it’s hard to see a non entranched company start investing on that without getting noticed.
I’d see it as the same situation as Camera makers when digital was coming at the horizon. They only needed to be there when the tech is ready, and had no need to bet the farm on making it a reality sooner than necessary.